EGFR and non-small cell lung carcinoma: For example, EGFR gene mutations in exons 18–21 detected in cfDNA or tumour cells from metastatic sites confirm NSCLC diagnosis with the same probability as pathological examination (Table 2) [17,29,30,35,36,37,38,39].